SCOPUS 정보 검색 플랫폼

Volumn 24, Issue 3, 2010, Pages 151-159

Repurposing strategies for therapeutics

Author keywords

Finasteride, therapeutic use; Milnacipran, therapeutic use; MLR 1023, therapeutic use; Paroxetine, therapeutic use; Pharmaceutical industry; Plerixafor, therapeutic use; Pramipexole, therapeutic use; Raloxifene, therapeutic use; Research and development; Ropinirole, therapeutic use; Sildenafil, therapeutic use; Therapeutic indications

Indexed keywords

IMATINIB; LOSARTAN; RAPAMYCIN; SILDENAFIL;

DRUG APPROVAL; DRUG COST; DRUG DEVELOPMENT; DRUG INDICATION; DRUG INDUSTRY; DRUG REPURPOSING; DRUG SAFETY; EXPIRATION DATE; NOTE; PHARMACEUTICS; PRIORITY JOURNAL;

EID: 77954813961 PISSN: 11782595 EISSN: 11791993 Source Type: Journal
DOI: 10.1007/BF03256811 Document Type: Note

Times cited : (135)

References (11)

1
- 84898694641
- [online]. Available from, [Accessed 2010 Jun 29]
- Pharmaceutical Research and Manufacturers of America (PhRMA) [online]. Available from URL: http://www.phrma.org/ [Accessed 2010 Jun 29]

2
- 84898690429
- US Food and Drug Administration [online]. Available from, [Accessed 2010 Jun 29]
- US Food and Drug Administration [online]. Available from URL: http:// www.fda.gov/ [Accessed 2010 Jun 29]

3
- 70350427662
- Drug discovery dilemma and Cura quartet collaboration
- Nov 14; 1006-1010
- Shah S, Federoff HJ.Drug discovery dilemma and Cura quartet collaboration. Drug Discovery Today 2009 Nov 14; 21-22: 1006-1010
- (2009) Drug Discovery Today , pp. 21-22
- Shah, S.¹ Federoff, H.J.²

4
- 73449101512
- Lessons from 60 years of pharmaceutical innovation
- Dec; 8:
- Munos B. Lessons from 60 years of pharmaceutical innovation. Nature Reviews Drug Discovery 2009 Dec; 8: 959-968
- (2009) Nature Reviews Drug Discovery , pp. 959-968
- Munos, B.¹

5
- 85036769958
- Surrey: MSI Consultancy
- Stuart-Kregor P. Drug repurposing. Surrey: MSI Consultancy, 2007
- (2007) Drug Repurposing
- Stuart-Kregor, P.¹

6
- 77954813725
- [online]. Available from, [Accessed 2010 Jun 3]
- Cutting Edge Information. Pharmaceutical product relaunch: preserving market share through line extension and new market entry strategies. 2007 [online]. Available from URL: http://www.cuttingedgeinfo.com/productrelaunch/? overview [Accessed 2010 Jun 3]
- (2007) Pharmaceutical Product Relaunch: Preserving Market Share Through Line Extension and New Market Entry Strategies

7
- 80255129935
- Integration of indications discovery efforts at Pfizer
- Barratt MJ, Frail DE. Integration of indications discovery efforts at Pfizer. International Drug Discovery 2010; 5: 72-75
- (2010) International Drug Discovery , vol.5 , pp. 72-75
- Barratt, M.J.¹ De, F.²

8
- 84898698411
- United States Securities and Exchange Commission: Washington D.C. 20549: form 10-Q [online]. Available from, [Accessed 2010 Jun 25]
- United States Securities and Exchange Commission: Washington D.C. 20549: form 10-Q [online]. Available from URL: http://www.sec.gov/Archives/ edgar/data/1043914/000115752307008179/a5467951.htm [Accessed 2010 Jun 25]

9
- 0141642224
- Medicine. The NIH roadmap
- Zerhouni E. Medicine. The NIH Roadmap. Science 2003; 302: 63-72
- (2003) Science , vol.302 , pp. 63-72
- Zerhouni, E.¹

10
- 73849083467
- Matchmaking service links up researchers to wallflower drugs [editorial]
- Jan;
- Schubert C. Matchmaking service links up researchers to wallflower drugs [editorial]. Nat Med 2009 Jan; 16 (1): 7
- (2009) Nat Med , vol.16 , Issue.1 , pp. 7
- Schubert, C.¹

11
- 20844439415
- Why big pharma needs to learn the three Rs [editorial analysis]
- June 1;
- Bradley D. Why big pharma needs to learn the three Rs [editorial analysis]. Nat Rev Drug Discov 2005 June 1; 4: 446
- (2005) Nat Rev Drug Discov , vol.4 , pp. 446
- Bradley, D.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.